갈망감의 신경생물학적 기전과 항갈망제의 임상적 사용

• 영문명: Neurobiological Basis of Craving and Anti-Craving Medications
• 발행기관: 대한신경정신의학회
• 저자명: 정영철(Young-Chul Jung)
• 간행물 정보: 『신경정신의학』제58권 제3호, 167~172쪽, 전체 6쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2019.08.31

영문 초록

Clinical studies published over the past two decades have consistently demonstrated the therapeutic efficacy and safety of anti-craving medications. To use anti-craving agents more effectively in clinical settings, it is important to set clear treatment goals. Because alcoholic patients have lost control of drinking alcohol, it is recommended to set ‘abstinence’ as a goal rather than ‘controlled drinking’. Indeed, the therapeutic effects of anti-craving medication are higher when abstinence is set as the target. On the other hand, if abstinence is the sole criterion, it is difficult to elicit the motivation of a patient who lacks motivation in clinical practice. In the case of patients who have not yet gained insight, the initial goal might be set to gradually reduce the amount of alcohol consumed and prevent at-risk heavy drinking. Even in this case, anti-craving can help clinically. To increase the effectiveness of anti-craving medications, it is best to start at least four to seven days after the patient has stopped drinking. If the patient has alcohol withdrawal symptoms, they should be treated first.

목차

갈망감의 신경생물학적 기전

현재 임상에서 사용하고 있는 항갈망제

항갈망제를 사용할 때 고려해야 할 사항들

요 약

키워드

Alcohol use disorder Craving Naltrexone Acamprosate